Benefits of Employee Screening

One person dies of melanoma every hour in the US. If you have 100 employees, chances are that one of them has melanoma and does not even know it. When detected and treated early the cure rate is about 100%; however, once a melanoma lesion grows to thicker than 0.5mm chances of survival decline rapidly.

DermDetect is changing the way skin cancer is diagnosed in the US through its Advanced Skin Cancer Screening (ASCS). The screenings take just 15-20 minutes and can be done at your location or at one of our offices nationwide.

When an employee gets melanoma there are many costs to consider:

  • * Loss of productivity
    • * Due to appointments and treatments
    • * Due to depression
  • * Increased costs of healthcare (as much as $1M dollars over the course of the disease)
  • * In the worst case, hiring and training a replacement

For the cost of just $249/employee per year you can have the peace of mind knowing that when an employee does get melanoma, it will be caught early which is better for them and better for you. The cost is a fraction of the cost of just one employee having melanoma. Also, the good will that your employees will feel toward their employer knowing that they are being cared for. 

ASCS uses several technologies to image and document the health of your skin. It starts with Full Body Imaging (FBI) where several images are acquired in standardized poses to document every spot or mole on your body and maps them to an avatar. In follow up screenings, this will aid in identifying new spots. Only 30% of the time melanoma comes from an existing mole, the other 70% they just appear. 

Next, our trained Dermographer will closely examine the skin to look for any spots that do not match your normal mole pattern. Then, close up clinical pictures are acquired followed by dermoscpoic images that allow us to see "into" the mole. The images are uploaded to Academic Dermatologists using our secure cloud server and a report is generated. The images and report are easily accessible using our free app. This information can also be easily shared with your physician and used for comparison while monitoring for changes.

qtq80-EL9NMh
Large group of Latin American people celebrating a victory with arms up - isolated over white background
DermDetect has joined with the Oregon Health & Science University (OHSU) Knight Cancer Institute to advance skin cancer research as part of research collaboration. With your OHSU consent, you can donate your Advanced Skin Cancer Screening (ASCS) data to OHSU’s research efforts. The collaboration’s goal is to collect data from over 100,000 consenting recipients of ASCSs in a groundbreaking effort focused on early detection of skin cancer to improve survival rates.
DermDetect_Logo_PMS_Tag_904x132